Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Pluristyx's iPSC platform provides therapeutic developers with a streamlined path from research to clinical application, offering high-quality, regulatory-compliant starting materials and advanced ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of preeclampsia, according to a study in ...

Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...

COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients, significantly prolonging their lives, new ...

A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...

A freshman Idaho lawmaker wants to ban most COVID-19 shots for the next decade, with a bill rooted in misconceptions about vaccines that thrived during the pandemic. The bill from Sen. Brandon Shippy, ...

The growing demand for gene therapy and mRNA vaccines is driving the need for highly purified plasmid DNA. Manufacturing companies are moving towards 'GMP' standards to meet clinical and commercial ...